The loss of FH causes hypermethylation in the promoter of the tumor suppressor cyclin-dependent kinase inhibitor 2A (CDKN2A), the hypermethylation of CDKN2A is a predictive factor for unfavorable prognosis of various cancers 145. The gene discussed is CDKN2A; the disease is cancer.